0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
msJAMA |

The Rise of Direct-to-Consumer Advertising of Prescription Drugs in the United States FREE

Alison J. Huang, MPhil
[+] Author Affiliations

Not Available


Not Available


JAMA. 2000;284(17):2240. doi:10.1001/jama.284.17.2240-JMS1101-1-2.
Text Size: A A A
Published online

Direct-to-consumer (DTC) advertising of prescription medications has rapidly become one of the most contentious issues facing the medical profession in the United States. Prior to the early 1980s, pharmaceutical companies promoted their prescription products exclusively to physicians, who were expected to act as "learned intermediaries" interpreting drug information for the general public.1 During the past 2 decades, however, changes in the political and regulatory climate, cultural shifts emphasizing the patient's role in making medical decisions, and expanding profits from drug sales have encouraged the industry to pursue more direct marketing strategies.2

Today, advertisements for prescription drugs dot the pages of popular magazines and punctuate television programs. A survey of 18 diverse lay magazines from 1989 to 1998 revealed a total of 320 distinct DTC ads, representing 101 brands and 14 categories of medical conditions.3 This year, pharmaceutical companies will spend more than a billion dollars marketing their drug products directly to consumers, compared to only $55 million in 1991.4 According to a recent survey, more than one third of patients have asked their physicians for information on drugs they have seen in a DTC ad, and nearly one fourth have asked for the drug itself.5 Perhaps more significantly, three quarters of the patients requesting drug prescriptions received them from their physicians.

Proponents argue that DTC promotion provides a service by increasing public awareness of medical conditions and encouraging informed communication between patients and providers. Furthermore, DTC ads encourage consumers to act as autonomous decision-makers, able to weigh the benefits and risks of their health choices.6 At the same time, critics fear that drug companies will trade on the public's lack of medical knowledge to obscure products' risks and adverse effects. Physicians complain that they must devote increasing amounts of scarce time to dissuading patients from taking drugs that advertising has led them to believe are unproblematic.

This month, MSJAMA explores some of the issues raised by the growth of DTC advertising of pharmaceutical products in the United States. How does DTC marketing affect the relationship between patients and physicians? What is the role of the government in ensuring that DTC advertisements are accurate and complete? Should the rise of DTC advertising change physicians' liability in suits brought by drug consumers? How does the rise of DTC advertising change our perspective on drug companies' traditional practice of marketing drugs to physicians?

REFERENCES

Hutton  MB Norplant litigation: creating an exception to the learned intermediary doctrine. Trial. 1996;3274- 78
Kessler  DAPine  WL The federal regulation of prescription drug advertising and promotion. JAMA. 1990;2642409- 2415
Link to Article
Wiles  MSBell  RAKravitz  RL Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Aff (Millwood). 2000;19110- 128
Link to Article
Hollon  MF Direct-to-consumer marketing of prescription drugs: creating consumer demand. JAMA. 1999;281382- 384
Link to Article
Not Available, Navigating the Medication Marketplace: How Consumers Choose.  Washington, DC American Pharmaceutical Association1997;
T'Hoen  E Direct-to-consumer advertising: for better profits or for better health? Am J Health-System Pharm. 1998;55594- 597

Figures

Tables

References

Hutton  MB Norplant litigation: creating an exception to the learned intermediary doctrine. Trial. 1996;3274- 78
Kessler  DAPine  WL The federal regulation of prescription drug advertising and promotion. JAMA. 1990;2642409- 2415
Link to Article
Wiles  MSBell  RAKravitz  RL Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Aff (Millwood). 2000;19110- 128
Link to Article
Hollon  MF Direct-to-consumer marketing of prescription drugs: creating consumer demand. JAMA. 1999;281382- 384
Link to Article
Not Available, Navigating the Medication Marketplace: How Consumers Choose.  Washington, DC American Pharmaceutical Association1997;
T'Hoen  E Direct-to-consumer advertising: for better profits or for better health? Am J Health-System Pharm. 1998;55594- 597

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.